Student or educator? Sign up with your school email and get 6 months of Pro free.
Cited by 2,135

The DOI matches its Crossref record; 132 of the 132 references it cites were found in a registry or an index.

Mechanistic Basis of Antimicrobial Actions of Silver Nanoparticles

Open access
Dakal, Tikam Chand, Kumar, Anu, Majumdar, Rita S., Yadav, Vinod · 2016 · Frontiers in Microbiology

Abstract

Multidrug resistance of the pathogenic microorganisms to the antimicrobial drugs has become a major impediment toward successful diagnosis and management of infectious diseases. Recent advancements in nanotechnology-based medicines have opened new horizons for combating multidrug resistance in microorganisms. In particular, the use of silver nanoparticles (AgNPs) as a potent antibacterial agent has received much attention. The most critical physico-chemical parameters that affect the antimicrobial potential of AgNPs include size, shape, surface charge, concentration and colloidal state. AgNPs exhibits their antimicrobial potential through multifaceted mechanisms. AgNPs adhesion to microbial cells, penetration inside the cells, ROS and free radical generation, and modulation of microbial signal transduction pathways have been recognized as the most prominent modes of antimicrobial action. On the other side, AgNPs exposure to human cells induces cytotoxicity, genotoxicity, and inflammatory response in human cells in a cell-type dependent manner. This has raised concerns regarding use of AgNPs in therapeutics and drug delivery. We have summarized the emerging endeavors that address current challenges in relation to safe use of AgNPs in therapeutics and drug delivery platforms. Based on research done so far, we believe that AgNPs can be engineered so as to increase their efficacy, stability, specificity, biosafety and biocompatibility. In this regard, three perspectives research directions have been suggested that include (1) synthesizing AgNPs with controlled physico-chemical properties, (2) examining microbial development of resistance toward AgNPs, and (3) ascertaining the susceptibility of cytoxicity, genotoxicity, and inflammatory response to human cells upon AgNPs exposure.

Overview

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.3389/fmicb.2016.01831

Cites

132 of 132 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

1 retracted

Show all 132 references

Research works printed but not linked: 26

  1. Ansari, 2011, Evaluation of antibacterial activity of silver nanoparticles against MSSA and MSRA on isolates from skin infections, Biol. Med., 3, 141
  2. Blecher, 2012, Nanotechnology and the diagnosis of dermatological infectious disease, J. Drugs Dermatol., 7, 846
  3. Çiftçi, 2013, Silver nanoparticles: cytotoxic, apoptotic, and necrotic effects on MCF-7 cells, Turk. J. Biol., 37, 573, 10.3906/biy-1302-21 · doi:10.3906/biy-1302-21
  4. El-Kheshen, 2012, Effect of reducing and protecting agents on size of silver nanoparticles and their anti-bacterial activity, Schol. Res. Librar., 4, 53
  5. Iniesta, 2006, Phospho-signaling pathway controls the localization and activity of a protease complex critical for bacterial cell cycle progression, Proc. Natl. Acad. Sci. U.S.A., 103, 10935, 10.1073/pnas.0604554103 · doi:10.1073/pnas.0604554103
  6. Jun, 2007, Preparation and characterization of antibacterial silver-containing nanofibers for wound dressing applications, J. US China Med. Sci., 4, 52
  7. Kim, 2005, The biocidal activity of nano-sized silver particles comparing with silver ion, Korean Soc. Environ. Eng., 27, 771
  8. Kreeinthong, 2014, Effects of short-term silver nanoparticle exposure on proliferative signaling pathway in human skin keratinocyte, J. Physiol. Biomed. Sci., 27, 48
  9. Kumar, 2014, Mechanistic study of antibacterial activity of biologically synthesized silver nanocolloids, Colloids Surfaces A, 449, 82, 10.1016/j.colsurfa.2014.02.027 · doi:10.1016/j.colsurfa.2014.02.027
  10. Li, 2013, Highly selective antibacterial activities of silver nanoparticles against Bacillus subtilis, J. Nanosci. Nanotechnol., 13, 6806, 10.1166/jnn.2013.7781 · doi:10.1166/jnn.2013.7781
  11. Lkhagvajav, 2011, Antimicrobial activity of colloidal silver nanoparticles prepared by sol gel method, Dig. J. Nanomater. Biostruct., 6, 149
  12. Maneewattanapinyo, 2011, An evaluation of acute toxicity of colloidal silver nanoparticles, J. Vet. Med. Sci., 73, 1417, 10.1292/jvms.11-0038 · doi:10.1292/jvms.11-0038
  13. Munger, 2015, Assessing orally bioavailable commercial silver nanoparticle product on human cytochrome P450 enzyme activity, Nanotoxicology, 9, 474, 10.3109/17435390.2014.948092 · doi:10.3109/17435390.2014.948092
  14. Namasivayam, 2011, Evaluation of anti-bacterial activity of silver nanoparticles synthesized from Candida glabrata and Fusarium oxysporum, Int. J. Med. Res., 1, 131
  15. Nateghi, 2014, Effect of silver nanoparticles morphologies on antimicrobial properties of cotton fabrics, J. Text. I., 105, 806, 10.1080/00405000.2013.855377 · doi:10.1080/00405000.2013.855377
  16. Pasupuleti, 2013, Biogenic silver nanoparticles using Rhinacanthus nasutus leaf extract: synthesis, spectral analysis, and antimicrobial studies, Int. J. Nanomed., 8, 3355, 10.2147/IJN.S49000 · doi:10.2147/ijn.s49000
  17. Paul, 2015, Nanosized silver (II) pyridoxine complex to cause greater inflammatory response and less cytotoxicity to RAW264.7 macrophage cells, Nanoscale Res. Lett., 10, 140, 10.1186/s11671-015-0848-9 · doi:10.1186/s11671-015-0848-9
  18. Pellieux, 2000, Bactericidal and virucidal activities of singlet oxygen generated by thermolysis of naphthalene endoperoxides, Methods Enzymol., 319, 197, 10.1016/S0076-6879(00)19020-2 · doi:10.1016/s0076-6879(00)19020-2
  19. Phong, 2009, Green synthesis of silver nanoparticles and silver colloidal solutions, J. Phys. Conf. Ser., 187, 012078, 10.1088/1742-6596/187/1/012078 · doi:10.1088/1742-6596/187/1/012078
  20. Porras-Gomez, 2012, Overview of Multidrug-Resistant Pseudomonas aeruginosa and novel therapeutic approaches, J. Biomater. Nanobiotechnology, 3, 519, 10.4236/jbnb.2012.324053 · doi:10.4236/jbnb.2012.324053
  21. Shrivastava, 2008, Nanomedicine: physiological principle of distribution, Dig. J. Nanomater. Bios., 3, 303
  22. Suganya, 2015, Size controlled biogenic silver nanoparticles as antibacterial agent against isolates from HIV infected patients, Spectrochim. Acta A Mol. Biomol. Spectrosc., 144, 266, 10.1016/j.saa.2015.02.074 · doi:10.1016/j.saa.2015.02.074
  23. Szmacinski, 2008, Correlation between scattering properties of silver particle arrays and fluorescence enhancement, Appl. Spectrosc., 62, 733, 10.1366/000370208784909553 · doi:10.1366/000370208784909553
  24. Xu, 2012, In vivo toxicity in reproductive organs of rabbit and in vitro cytotoxicity of silver nanoparticle based-hydrogel, Chi. J. Pharm. Anal., 2, 194
  25. Xu, 2011, Toxicity of silver nanoparticles as assessed by global gene expression analysis, Mater. Express., 1, 74, 10.1166/mex.2011.1010 · doi:10.1166/mex.2011.1010
  26. Yin, 2003, Electrochemical synthesis of silver nanoparticles under protection of poly (N-vinylpyrrolidone), J. Phys. Chem. B., 107, 8898, 10.1021/jp0349031 · doi:10.1021/jp0349031

Cited by

Metadata

Authors
Dakal, T. C., Kumar, A., Majumdar, R. S., & Yadav, V.
Venue
Frontiers in Microbiology
Published
2016-11-16
Volume
7
Pages
1831-1831
ISSN
1664-302X (ISSN-L)
OpenAlex
W2549644565
Cited by
2,135
References
132
FWCI
38.42
Type
journal article
Language
en
Open access
gold

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.